Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction | Zendy

Doo Sun Sim | Zendy; Myung Ho Jeong | Zendy; Youngkeun Ahn | Zendy; Young Jo Kim | Zendy; Shung Chull Chae | Zendy; Taek Jong Hong | Zendy; In Whan Seong | Zendy; Jei Keon Chae | Zendy; Chong Jin Kim | Zendy; MyeongChan Cho | Zendy; SeungWoon Rha | Zendy; Jang Ho Bae | Zendy; Ki Bae Seung | Zendy; SeungJung Park | Zendy

Open Access

Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction

Author(s) -

Doo Sun Sim,

Myung Ho Jeong,

Youngkeun Ahn,

Young Jo Kim,

Shung Chull Chae,

Taek Jong Hong,

In Whan Seong,

Jei Keon Chae,

Chong Jin Kim,

MyeongChan Cho,

SeungWoon Rha,

Jang Ho Bae,

Ki Bae Seung,

SeungJung Park

Publication year - 2016

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.115.003508

Subject(s) - medicine , myocardial infarction , percutaneous coronary intervention , cardiology , fibrinolysis , timi , thrombolysis , reperfusion therapy , st segment

The Strategic Reperfusion Early After Myocardial Infarction trial and the French Registry of Acute ST-elevation or Non-ST-elevation Myocardial Infarction 2015 suggested that pharmacoinvasive strategy compares favorably with primary percutaneous coronary intervention (PPCI). We sought to assess the clinical impact of pharmacoinvasive strategy compared with PPCI in real-world patients with ST-segment-elevation myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research